Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Obesity appears to increase the risk of prostate cancer

The obesity study examined the association between body mass index - weight to height ratio - and prostate cancer in 787 men undergoing biopsy due to an elevated tumor marker in the blood or an abnormal physical exam at a Veterans Affairs hospital in California between 1998 and 2002.

23 May 2005

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Results of a major trial of hormone therapy on men with locally advanced prostate cancer announced today were a significant development and would be welcomed by patients and oncologists world-wide, according to The Cancer Council Australia.

23 May 2005

Being married or in a relationship significantly improves quality of life for prostate cancer patients following treatment

Partnered men reported better psychosocial and spiritual well-being, suffered fewer adverse effects from treatment and had less fear and anxiety about their cancer coming back than did their single counterparts, the study found.

23 May 2005

Scientists show nuclear protein Ezh2 helps establish previously unknown signaling pathway in cells

Since 2001, scientists have wrestled with the discovery that there are fewer genes in humans than biological processes linked to those genes over the course of a human lifespan. One way to understand genetically coded events is by studying epigenetics, the regulation and heritability of genes at a cellular level due to molecular changes to the many proteins (called histones) that package DNA in a cell's nucleus.

23 May 2005

Drug used to treat enlarged prostate may improve the accuracy of prostate biopsies

The drug, dutasteride, suppresses blood flow in benign tissue of the prostate, allowing radiologists to better target cancer tissue using Doppler ultrasound, said Elizabeth Ives, MD, a research fellow at Thomas Jefferson University Hospital in Philadelphia and lead author of the study.

20 May 2005

Testosterone appears to benefit, not harm, cardiovascular health of middle-aged men

Although men suffer more coronary heart disease than women, the blame should not be placed on testosterone, according to a new study in the May 17, 2005, issue of the Journal of the American College of Cardiology.

18 May 2005

New blood tests for both prostate and colon cancer

Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.

18 May 2005

Unlucky news for Kylie Minogue

The 36-year-old Australian Pop Diva was diagnosed with breast cancer while visiting her family at home in Melbourne, her management confirmed.

17 May 2005

Vitamin D, taxotere combination promising for advanced prostate cancer

Results of a new study strongly suggest that DN-101, a new high-dose calcitriol pill designed specifically as a cancer therapy, given in combination with docetaxel (Taxotere) extends the lives of men with advanced prostate cancer.

17 May 2005

Antibody combined with cancer drug shows promise against breast tumors

An antibody that targets the blood vessels nourishing tumors significantly reduced breast cancer formation and growth in mice when combined with a current cancer drug, according to researchers at UT Southwestern Medical Center.

16 May 2005

Drugs that block the enzyme Odc prevent the onset of cancers

The drug DFMO prevents cancer in laboratory models of lymphoma but fails to kill existing cancerous cells that have lost the ability to self-destruct, according to investigators at St. Jude Children's Research Hospital.

16 May 2005

Identifying high-risk prostate cancer means more prudent treatment decisions

While prostate cancer is a very common diagnosis, it is a deadly disease in relatively few men. One in 6 men will develop prostate cancer during his lifetime. However, of these, only one in 10 cases will be life-threatening.

16 May 2005

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Final results from the largest international study in the treatment of advanced stomach cancer, also known as gastric cancer, demonstrated that patients who received a Taxotere (docetaxel) Injection Concentrate-based chemotherapy regimen (Taxotere, cisplatin and 5-fluorouracil) had significantly improved overall survival rates compared to patients who received a standard treatment (cisplatin and 5- fluorouracil).

16 May 2005

Zometa reduces bone loss in patients receiving breast cancer treatment

Data presented at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Florida, demonstrate that Zometa (zoledronic acid), an intravenous bisphosphonate, was shown to inhibit bone loss in postmenopausal women treated with Femara (letrozole) in the adjuvant breast cancer setting (directly following surgery to prevent cancer recurrence).

16 May 2005

Cancer can be found earlier in high-risk men if more aggressive screening criteria used

Men at high risk of developing prostate cancer should undergo aggressive screening for the disease. That is the recommendation following a Fox Chase Cancer Center study of 520 men at high-risk of developing prostate cancer in which 25 percent were diagnosed with the disease despite having a low PSA. The findings were presented today at the American Society of Clinical Oncology 41st Annual Meeting.

15 May 2005

Breast cancer hormone drug might help prevent prostate cancer

A hormonal drug used to fight breast cancer might help prevent abnormal prostate growths from turning into cancers.

15 May 2005

Prostate cancer drug, Omnitarg by Genentech falls short

Research into an experimental prostate cancer drug being developed by Genentech Inc. will probably be abandoned after scientists found that the drug failed to prove effective in a mid-stage trial.

15 May 2005

New study says surgery still the best option for prostate cancer

A study by Swedish researchers has found that men who opt to have cancerous prostates surgically removed, have higher long-term survival rates than those who delay the operation, and the benefits of surgery may be greatest for men under 65.

11 May 2005

Discovery may pave way for immunotherapies for prostate cancer

Using a common chemotherapy agent, researchers at UCLA's Jonsson Cancer Center and the Department of Pathology and Laboratory Medicine found a way to move an important biomarker expressed in prostate cancer, shaking it loose from one location in a cell – where it could not be accessed by blood – to another, easier to target area.

11 May 2005

Cytogen Corporation and Dowpharma collaborate to create a targeted oncology product designed to treat prostate and other cancers

Under the agreement, Dowpharma's proprietary MeO-DOTA bifunctional chelant technology will be used to radiolabel Cytogen's prostate-specific membrane antigen (PSMA) antibody with a therapeutic radionuclide. PSMA is a protein highly expressed on the surface of prostate cancer cells and the neovasculature of many solid tumors.

10 May 2005

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Obesity appears to increase the risk of prostate cancer

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Being married or in a relationship significantly improves quality of life for prostate cancer patients following treatment

Scientists show nuclear protein Ezh2 helps establish previously unknown signaling pathway in cells

Drug used to treat enlarged prostate may improve the accuracy of prostate biopsies

Testosterone appears to benefit, not harm, cardiovascular health of middle-aged men

New blood tests for both prostate and colon cancer

Unlucky news for Kylie Minogue

Vitamin D, taxotere combination promising for advanced prostate cancer

Antibody combined with cancer drug shows promise against breast tumors

Drugs that block the enzyme Odc prevent the onset of cancers

Identifying high-risk prostate cancer means more prudent treatment decisions

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Zometa reduces bone loss in patients receiving breast cancer treatment

Cancer can be found earlier in high-risk men if more aggressive screening criteria used

Breast cancer hormone drug might help prevent prostate cancer

Prostate cancer drug, Omnitarg by Genentech falls short

New study says surgery still the best option for prostate cancer

Discovery may pave way for immunotherapies for prostate cancer

Cytogen Corporation and Dowpharma collaborate to create a targeted oncology product designed to treat prostate and other cancers

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in